Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes, 13988-13989 [2011-6020]
Download as PDF
<![CDATA[
13988
Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices
Estimated time
for response
(in minutes)
Item
Revocation of Attorney/Domestic Representative and/or Appointment of Attorney/Domestic
Representative (Paper) ............................................................................................................
TEAS Revocation of Attorney/Domestic Representative and/or Appointment of Attorney/Domestic Representative (PTO Form 2196) ................................................................................
Request for Permission to Withdraw as Attorney of Record (Paper) .........................................
TEAS Request for Permission to Withdraw as Attorney of Record (PTO Form 2201) ..............
Change of Owner’s Address (Paper) ..........................................................................................
TEAS Change of Owner’s Address (PTO Form 2197) ...............................................................
Change of Domestic Representative’s Address (Paper) ............................................................
TEAS Change of Domestic Representative’s Address (TEAS Global) ......................................
Replacement of Attorney of Record with Another Already-Appointed Attorney (Paper) ............
TEAS Replacement of Attorney of Record with Another Already-Appointed Attorney (TEAS
Global) ......................................................................................................................................
Request to Withdraw as Domestic Representative (Paper) .......................................................
TEAS Request to Withdraw as Domestic Representative (TEAS Global) .................................
Estimated
annual
responses
10
4,000
680
5
15
12
10
5
10
5
10
80,000
225
4,500
1,600
32,000
13
250
1
6,400
56
900
272
2,560
2
20
1
5
10
5
1
20
400
1
3
32
123,010
10,927
Totals ....................................................................................................................................
Estimated Total Annual Non-Hour
Respondent Cost Burden: $2,526. This
information collection has postage costs
associated with it. It does not have any
operation or maintenance costs, nor
does it have filing fees.
Customers incur postage costs when
submitting the information in paper
format. The USPTO estimates that the
majority (98%) of paper submissions are
submitted via United States Postal
Service first-class mail. The USPTO
estimates these submissions will weigh
approximately one ounce with a firstclass postage rate of 44 cents. Out of
5,859 paper submissions, the USPTO
estimates that 5,741 will be mailed, for
a total non-hour respondent cost burden
of $2,526 in postage costs.
Postage costs
($)
(b)
Responses
(a)
Item
Estimated
annual
burden hours
Total non-hour
cost burden
(a × b)
(c)
Revocation of Attorney/Domestic Representative and/or Appointment of Attorney/Domestic
Representative .........................................................................................................................
Request for Permission to Withdraw As Attorney of Record ......................................................
Change of Owner’s Address Form ..............................................................................................
Change of Domestic Representative’s Address ..........................................................................
Replacement of Attorney of Record with Another Already-Appointed Attorney .........................
Request to Withdraw as Domestic Representative .....................................................................
3,920
221
1,568
12
1
19
$0.44
0.44
0.44
0.44
0.44
0.44
$1,725.00
97.00
690.00
5.00
1.00
8.00
Totals ....................................................................................................................................
5,741
........................
2,526.00
srobinson on DSKHWCL6B1PROD with NOTICES
IV. Request for Comments
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, e.g., the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized or
included in the request for OMB
approval of this information collection;
they will also become a matter of public
record.
VerDate Mar<15>2010
16:50 Mar 14, 2011
Jkt 223001
Dated: March 10, 2011.
Susan K. Fawcett,
Records Officer, USPTO, Office of the Chief
Information Officer.
[FR Doc. 2011–5902 Filed 3–14–11; 8:45 am]
BILLING CODE 3510–16–P
CONSUMER PRODUCT SAFETY
COMMISSION
Notice of Meeting of Chronic Hazard
Advisory Panel on Phthalates and
Phthalate Substitutes
Consumer Product Safety
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Consumer Product
Safety Commission (‘‘CPSC’’ or
‘‘Commission’’) announces the fourth
meeting of the Chronic Hazard Advisory
Panel (CHAP) on phthalates and
phthalate substitutes. The Commission
SUMMARY:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
appointed this CHAP to study the
effects on children’s health of all
phthalates and phthalate alternatives as
used in children’s toys and child care
articles, pursuant to section 108 of the
Consumer Product Safety Improvement
Act of 2008 (CPSIA) (Pub. L. 110–314).
DATES: The meeting will be held on
Wednesday, March 30, 2011, and
Thursday, March 31, 2011. The meeting
will begin at approximately 8 a.m. on
both days. It will end at approximately
5 p.m. on Wednesday and at
approximately 3 p.m. on Thursday.
ADDRESSES: The meeting will be held in
Room 410 at the Commission’s offices at
4330 East West Highway, Bethesda, MD
20814.
Registration and Webcast: Members of
the public who wish to attend the
meeting may register on the day of the
meeting. There will not be any
opportunity for public participation at
this meeting. A live Webcast will not be
E:\FR\FM\15MRN1.SGM
15MRN1
Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices
available. However, the meeting will be
recorded and posted on the CPSC’s Web
site.
FOR FURTHER INFORMATION CONTACT:
Michael Babich, Directorate for Health
Sciences, U.S. Consumer Product Safety
Commission, Bethesda, MD 20814;
telephone (301) 504–7253; e-mail
mbabich@cpsc.gov.
Section
108 of the CPSIA permanently prohibits
the sale of any ‘‘children’s toy or child
care article’’ containing more than 0.1
percent of each of three specified
phthalates—di-(2-ethylhexyl) phthalate
(DEHP), dibutyl phthalate (DBP), and
benzyl butyl phthalate (BBP). Section
108 of the CPSIA also prohibits, on an
interim basis, the sale of any ‘‘children’s
toy that can be placed in a child’s
mouth’’ or ‘‘child care article’’ containing
more than 0.1 percent of each of three
additional phthalates—diisononyl
phthalate (DINP), diisodecyl phthalate
(DIDP), and di-n-octyl phthalate
(DNOP).
Moreover, section 108 of the CPSIA
requires the Commission to convene a
CHAP ‘‘to study the effects on children’s
health of all phthalates and phthalate
alternatives as used in children’s toys
and child care articles.’’ The CPSIA
requires the CHAP to complete an
examination of the full range of
phthalates that are used in products for
children and:
• Examine all of the potential health
effects (including endocrine disrupting
effects) of the full range of phthalates;
• Consider the potential health effects
of each of these phthalates, both in
isolation and in combination with other
phthalates;
• Examine the likely levels of
children’s, pregnant women’s, and
others’ exposure to phthalates, based
upon a reasonable estimation of normal
and foreseeable use and abuse of such
products;
• Consider the cumulative effect of
total exposure to phthalates, from
children’s products and from other
sources, such as personal care products;
• Review all relevant data, including
the most recent, best available, peerreviewed, scientific studies of these
phthalates and phthalate alternatives
that employ objective data-collection
practices or employ other objective
methods;
• Consider the health effects of
phthalates not only from ingestion but
also as a result of dermal, hand-tomouth, or other exposure;
• Consider the level at which there is
a reasonable certainty of no harm to
children, pregnant women, or other
susceptible individuals and their
srobinson on DSKHWCL6B1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
16:50 Mar 14, 2011
Jkt 223001
offspring, reviewing the best available
science, and using sufficient safety
factors to account for uncertainties
regarding exposure and susceptibility of
children, pregnant women, and other
potentially susceptible individuals; and
• Consider possible similar health
effects of phthalate alternatives used in
children’s toys and child care articles.
The CPSIA contemplates completion
of the CHAP’s examination within 18
months of the panel’s appointment. The
CHAP must review prior work on
phthalates by the Commission, but the
prior work is not to be considered
determinative, as the CHAP’s
examination must be conducted de
novo.
The CHAP must make
recommendations to the Commission
which phthalates (or combinations of
phthalates) in addition to those
identified in section 108 of the CPSIA
or phthalate alternatives that the panel
determines should be prohibited from
use in children’s toys or child care
articles or otherwise restricted. The
CHAP members were selected by the
Commission from scientists nominated
by the National Academy of Sciences.
See 15 U.S.C. 2077, 2030(b).
The CHAP met previously in April,
July, and December 2010. The CHAP
heard testimony from interested parties
at the July meeting. The March 2011
meeting will include discussion of the
CHAP’s progress toward its analysis of
potential risks from phthalates and
phthalate substitutes. There will not be
any opportunity for public comment at
the March 30–31 meeting.
Dated: March 10, 2011.
Todd A. Stevenson,
Secretary.
[FR Doc. 2011–6020 Filed 3–14–11; 8:45 am]
BILLING CODE 6355–01–P
CORPORATION FOR NATIONAL AND
COMMUNITY SERVICE
Information Collection; Submission for
OMB Review, Comment Request
Corporation for National and
Community Service.
ACTION: Notice.
AGENCY:
The Corporation for National
and Community Service (hereinafter the
‘‘Corporation’’), has submitted a public
information collection request (ICR)
entitled the Senior Corps Grant
Application to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995,
Public Law 104–13 (44 U.S.C. chapter
SUMMARY:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
13989
35). Copies of this ICR, with applicable
supporting documentation, may be
obtained by calling the Corporation for
National and Community Service, Ms.
Angela Roberts, at (202) 606–6822,
(aroberts@cns.gov). Individuals who use
a telecommunications device for the
deaf (TTY–TDD) may call (202) 606–
3472 between 8:30 a.m. and 5 p.m.
Eastern time, Monday through Friday.
ADDRESSES: Comments may be
submitted, identified by the title of the
information collection activity, to the
Office of Information and Regulatory
Affairs, Attn: Ms. Sharon Mar, OMB
Desk Officer for the Corporation for
National and Community Service, by
any of the following two methods
within 30 days from the date of
publication in the Federal Register:
(1) By fax to: (202) 395–6974, Attention:
Ms. Sharon Mar, OMB Desk Officer
for the Corporation for National and
Community Service; and
(2) Electronically by e-mail to:
smar@omb.eop.gov.
The OMB
is particularly interested in comments
which:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Corporation, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Propose ways to enhance the
quality, utility, and clarity of the
information to be collected; and
• Propose ways to minimize the
burden of the collection of information
on those who are to respond, including
through the use of appropriate
automated, electronic, mechanical, or
other technological collection
techniques or other forms of information
technology, e.g., permitting electronic
submissions of responses.
SUPPLEMENTARY INFORMATION:
Comments
A 60-day public comment Notice was
published in the Federal Register on
December 14, 2010. This comment
period ended February 14, 2011. The
following summarizes the public
comments received from the Notice
summary:
(a) Two commenters supported the
change and noted that an Executive
Summary would add minimal burden to
the application process. (b) Five
commenters requested more details
about the Executive Summary, asking
what an Executive Summary is and
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 76, Number 50 (Tuesday, March 15, 2011)]
[Notices]
[Pages 13988-13989]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-6020]
=======================================================================
-----------------------------------------------------------------------
CONSUMER PRODUCT SAFETY COMMISSION
Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates
and Phthalate Substitutes
AGENCY: Consumer Product Safety Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Consumer Product Safety Commission (``CPSC'' or
``Commission'') announces the fourth meeting of the Chronic Hazard
Advisory Panel (CHAP) on phthalates and phthalate substitutes. The
Commission appointed this CHAP to study the effects on children's
health of all phthalates and phthalate alternatives as used in
children's toys and child care articles, pursuant to section 108 of the
Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110-
314).
DATES: The meeting will be held on Wednesday, March 30, 2011, and
Thursday, March 31, 2011. The meeting will begin at approximately 8
a.m. on both days. It will end at approximately 5 p.m. on Wednesday and
at approximately 3 p.m. on Thursday.
ADDRESSES: The meeting will be held in Room 410 at the Commission's
offices at 4330 East West Highway, Bethesda, MD 20814.
Registration and Webcast: Members of the public who wish to attend
the meeting may register on the day of the meeting. There will not be
any opportunity for public participation at this meeting. A live
Webcast will not be
[[Page 13989]]
available. However, the meeting will be recorded and posted on the
CPSC's Web site.
FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health
Sciences, U.S. Consumer Product Safety Commission, Bethesda, MD 20814;
telephone (301) 504-7253; e-mail mbabich@cpsc.gov.
SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently
prohibits the sale of any ``children's toy or child care article''
containing more than 0.1 percent of each of three specified
phthalates--di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate
(DBP), and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also
prohibits, on an interim basis, the sale of any ``children's toy that
can be placed in a child's mouth'' or ``child care article'' containing
more than 0.1 percent of each of three additional phthalates--
diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-
octyl phthalate (DNOP).
Moreover, section 108 of the CPSIA requires the Commission to
convene a CHAP ``to study the effects on children's health of all
phthalates and phthalate alternatives as used in children's toys and
child care articles.'' The CPSIA requires the CHAP to complete an
examination of the full range of phthalates that are used in products
for children and:
Examine all of the potential health effects (including
endocrine disrupting effects) of the full range of phthalates;
Consider the potential health effects of each of these
phthalates, both in isolation and in combination with other phthalates;
Examine the likely levels of children's, pregnant women's,
and others' exposure to phthalates, based upon a reasonable estimation
of normal and foreseeable use and abuse of such products;
Consider the cumulative effect of total exposure to
phthalates, from children's products and from other sources, such as
personal care products;
Review all relevant data, including the most recent, best
available, peer-reviewed, scientific studies of these phthalates and
phthalate alternatives that employ objective data-collection practices
or employ other objective methods;
Consider the health effects of phthalates not only from
ingestion but also as a result of dermal, hand-to-mouth, or other
exposure;
Consider the level at which there is a reasonable
certainty of no harm to children, pregnant women, or other susceptible
individuals and their offspring, reviewing the best available science,
and using sufficient safety factors to account for uncertainties
regarding exposure and susceptibility of children, pregnant women, and
other potentially susceptible individuals; and
Consider possible similar health effects of phthalate
alternatives used in children's toys and child care articles.
The CPSIA contemplates completion of the CHAP's examination within
18 months of the panel's appointment. The CHAP must review prior work
on phthalates by the Commission, but the prior work is not to be
considered determinative, as the CHAP's examination must be conducted
de novo.
The CHAP must make recommendations to the Commission which
phthalates (or combinations of phthalates) in addition to those
identified in section 108 of the CPSIA or phthalate alternatives that
the panel determines should be prohibited from use in children's toys
or child care articles or otherwise restricted. The CHAP members were
selected by the Commission from scientists nominated by the National
Academy of Sciences. See 15 U.S.C. 2077, 2030(b).
The CHAP met previously in April, July, and December 2010. The CHAP
heard testimony from interested parties at the July meeting. The March
2011 meeting will include discussion of the CHAP's progress toward its
analysis of potential risks from phthalates and phthalate substitutes.
There will not be any opportunity for public comment at the March 30-31
meeting.
Dated: March 10, 2011.
Todd A. Stevenson,
Secretary.
[FR Doc. 2011-6020 Filed 3-14-11; 8:45 am]
BILLING CODE 6355-01-P
